SR | The availability, cost, and affordability of essential medicines for asthma and COPD in low- and middle-income countries.
11 Nov, 2022 | 13:04h | UTCInvited Commentary: Access to essential respiratory medications remains elusive in LMICs – The Lancet Global Health